Lone Star Fund XII Affiliate Acquires Lonza Capsules & Health Ingredients (CHI) Division
March 9, 2026
Lone Star Fund XII, L.P. is acquiring Lonza Group AG’s Capsules & Health Ingredients (CHI) division under a definitive agreement. Lonza will retain a 40% equity position, with the business positioned as a standalone global platform serving pharmaceutical, nutraceutical, and nutrition ingredient markets. The transaction is subject to customary closing conditions and regulatory approvals.
- Targets
- Capsules & Health Ingredients (CHI) division of Lonza Group AG, Capsules 26 Health Ingredients (CHI) division of Lonza Group AG, Capsules & Health Ingredients (CHI) division of Lonza Group AG
- Sellers
- Lonza Group AG
- Platforms
- Capsules & Health Ingredients (CHI) division of Lonza Group AG
- Industry
- Healthcare Services
- Location
- Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Lone Star Funds to Acquire ContiTech from Continental AG
July 6, 2026
Industrial Services
Lone Star Funds, through an affiliate of Lone Star Fund XIII, has entered into a definitive agreement to acquire ContiTech, the material solutions group of Continental AG, for €4.0 billion (plus performance-based components up to €250 million). The transaction is intended to position ContiTech as a standalone industrial company focused on further development of its platform and product suite.
-
Lone Star acquires RadiciGroup Specialty Chemicals and High Performance Polymers; Radici retains textiles via Raditex
May 3, 2026
Manufacturing
Lone Star Fund XII has formally closed its acquisition of RadiciGroup’s Business Area Specialty Chemicals and High Performance Polymers from RadiciGroup. The Radici family retained the textile business, which has been merged into a new entity called Raditex.
-
Lone Star Acquires Domo Chemicals Italy from Belgian Domo Group
May 1, 2026
Manufacturing
Domo Chemicals Italy (including Domo Engineering Plastics Italy and Domo Engineering Plastics Europe) has been sold to the Anglo-American private equity fund Lone Star. The agreement was completed, transferring ownership of the Linfano-based technopolymers business with about 130 employees.
-
Lone Star Completes All-Cash Acquisition of Hillenbrand
February 10, 2026
Industrial Services
An affiliate of Lone Star Funds completed an all-cash take-private acquisition of Hillenbrand, Inc. for an enterprise value of approximately $3.8 billion. Hillenbrand’s common stock ceased trading and will be delisted from the New York Stock Exchange, while the company will continue operating under the Hillenbrand name.
-
Turnspire Capital Partners Completes Acquisition of Pharmachem Innovations from Ashland
September 3, 2024
Food & Beverage
Turnspire Capital Partners has acquired Pharmachem Innovations, the former nutraceuticals business of Ashland Inc., creating an independent nutraceuticals platform. Pharmachem — a provider of proprietary nutrition ingredients, custom formulation and contract manufacturing with ~500 employees across facilities in New Jersey, Utah and Tamaulipas, Mexico — will be led by Executive Chairman Maurice Murphy and Interim CEO Jeff Rogers as Turnspire pursues operational growth opportunities.
-
Bain Capital and Cinven to Acquire Lonza Specialty Ingredients
February 8, 2021
Manufacturing
Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.